DeepTech Investor Summit

Odne AG

ETH spin-off

odne.co/Dübendorf, Switzerland
11 profile visits

About

**Odne AG (formerly Lumendo AG), has its roots in a groundbreaking collaboration between two renowned Swiss institutions: the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL & ETH Zürich).
Founded in 2018, Odne’s journey began by licensing cutting-edge technology assets from these esteemed institutes and starting product development in close collaboration with dental KOLs and Universities.

In 2023, Odne received FDA-clearance for OdneFill and OdneCure. FDA-clearance for OdneClean followed in 2024. To support the US launch, Odne founded Odne Inc. and started its product launch with a Priority Access Program (PAP) at AAE 2024 meeting in Los Angeles.

Odne is transforming endo by pioneering the future of endodontics through advanced technology solutions. The Odne Root Preservation Therapy (RPT) is a paradigm shift in endodontics. Instead of shaping to fit a cone, Odne RPT cleans and obturates complex root canal morphologies, preserving anatomic structures.**

Social media

Target Markets of your organization / Expansion or target markets of your spin-off

US

Covered funding stages of your organization / Spin-off Funding Stage

Series B

Industry Sector your organization invests in / Industry Sector of your Spin-off

Med Tech

Representatives

Odne AG

CEO and Co-Founder of Odne AG

Odne AG

COO & Co-founder

Odne AG